Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M66.6Revenue (TTM) $M119Net Margin (%)-39.1Altman Z-Score-4.9
Enterprise Value $M-25.4EPS (TTM) $-1.0Operating Margin %-39.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-39.2Higher ROA y-yY
Price/Book0.710-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsN
Price/Sales2.45-y EBITDA Growth Rate %-13.0Current Ratio4.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-19.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-46.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M49.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 1.34-96%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 1.34-97%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 1.34-95%New holding75,000
INFIFirst Eagle Investment 2012-06-30 Sold Out -0.0086%$11.84 - $13.88
($12.85)
$ 1.34-90%Sold Out0
INFIFirst Eagle Investment 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 1.34-83%Reduce -54.94%180,000
INFIFirst Eagle Investment 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 1.34-83%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 1.34-79%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 1.34-78%Reduce -63.91%7,415
INFIFirst Eagle Investment 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 1.34-78%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 1.34-76%Reduce -25.39%20,545
INFIFirst Eagle Investment 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 1.34-76%Add 29.72%365,123
INFIFirst Eagle Investment 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 1.34-80%Add 566.95%281,460
INFIFirst Eagle Investment 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 1.34-77%Add 451.43%42,201
INFIFirst Eagle Investment 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 1.34-81%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 1.34-83%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-02Buy201,394$1.1912.61view
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-87.74view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-87.78view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-89.54view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-89view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-91.63view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-91.88view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-90.96view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-90.96view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-91.79view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
INFINITY PHARMACEUTICALS, INC. Financials Nov 17 2016
Infinis plc announces second quarter results for year ending 31.03.17 £350m 7% Senior Notes due... Nov 16 2016
Infinity (INFI) Reports Narrower-than-Expected Loss in Q3 Nov 11 2016
Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up On Opdivo... Nov 10 2016
Blog Coverage Bristol-Myers Squibb and Infinity Pharma Collaborate for Clinical Trials to Test... Nov 10 2016
Edited Transcript of INFI earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
Infinity reports 3Q loss Nov 09 2016
Infinity reports 3Q loss Nov 09 2016
Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today Nov 09 2016
Infinity Provides Company Update and Reports Third Quarter 2016 Financial Results Nov 09 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 09 2016
Infinity Provides Company Update and Reports Third Quarter 2016 Financial Results Nov 09 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016
Infinity Announces Second Publication on PI3K-Gamma in Nature Nov 09 2016
Infinity Announces Second Publication on PI3K-Gamma in Nature Nov 09 2016
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo... Nov 09 2016
Q3 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close Nov 09 2016
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo... Nov 09 2016
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo... Nov 09 2016
Endo (ENDP) Q3 Earnings & Revenues Beat; View Intact Nov 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)